[Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus].
Fölsch
U R
UR
Klinik für Allgemeine Innere Medizin, Universität Kiel.
Lembcke
B
B
D020909:Acarbose; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000201:enzymology*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000201:enzymology*; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D007413:Intestinal Mucosa / Q000201:enzymology*; D014312:Trisaccharides / Q000009:adverse effects / Q000627:therapeutic use*
D001786:Blood Glucose; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D014312:Trisaccharides; D020909:Acarbose
Inhibition der intestinalen Alpha-Glukosidasen in der Therapie des Diabetes mellitus.